Skip to main content
Skip to main content
VTR logo

Ventas, Inc. (VTR)

$92.57 +$2.92 (+3.26%) |Fair · 52
Bottom line: HOLD — our Council read (52/100) and AI Score (52/100) broadly agree.
MCap: $45.00B| P/E Ratio: 153.0| Vol: 2.58M| Target: $98.22 (+6.1%)| 52-wk range: $61.76 – $91.06
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Ventas, Inc. (VTR) trades at $92.57 with AI Score 52/100 (Grade B). Ventas, Inc. is a leading Real Estate Investment Trust (REIT) specializing in healthcare properties. Market cap: $45.00B, Sector: Real estate.

Price live · AI analysis from May 5, 2026
Ventas, Inc. is a leading Real Estate Investment Trust (REIT) specializing in healthcare properties. The company owns and manages a diversified portfolio of senior housing, medical office, and life science facilities.

VTR stock analysis for 2026: Analysts have set a consensus price target of $98.22 for Ventas, Inc., suggesting 6.1% upside from the current price of $92.57. The AI MoonshotScore is 52/100, indicating a neutral outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
HOLD 52/100 · B

VTR: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Ventas, Inc. (VTR) Real Estate Portfolio & Strategy

CEODebra A. Cafaro
Employees498
HeadquartersChicago, IL, US
IPO Year1997

Ventas, Inc. (VTR) is a leading S&P 500 REIT investing in healthcare and senior living properties. Ventas partners with healthcare providers and research institutions, leveraging demographic trends to drive consistent cash flow and shareholder returns. The company's diversified portfolio and experienced management team position it as a key player in the healthcare real estate sector.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 5, 2026

What Is the Investment Thesis for VTR?

Ventas, Inc. presents a notable research candidate within the healthcare REIT sector. The company's diversified portfolio of healthcare properties, including senior housing, medical office buildings, and life science facilities, positions it to benefit from the aging population and increasing demand for healthcare services. Ventas' focus on partnering with leading care providers and research institutions enhances its competitive advantage. With a dividend yield of 2.26% and a beta of 0.77, Ventas offers a blend of income and relative stability. The company's P/E ratio of 153.0 suggests a premium valuation, reflecting investor confidence in its long-term growth prospects. Key catalysts include strategic acquisitions and development projects that expand its portfolio and enhance its revenue streams. However, investors should be aware of potential risks, such as interest rate fluctuations and regulatory changes in the healthcare industry.

Based on FMP financials and quantitative analysis

VTR Key Highlights

  • Market capitalization of $45.00B, reflecting its significant presence in the REIT sector.
  • P/E ratio of 153.0, indicating investor expectations for future growth.
  • Dividend yield of 2.26%, providing a steady income stream for investors.
  • Beta of 0.77, suggesting lower volatility compared to the overall market.
  • Operates approximately 1,200 properties as of September 30, 2020, showcasing its extensive portfolio.

Who Are VTR's Competitors?

VTR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
CCI Crown Castle Inc. $76.60 +0.09% $33.43B 52
IRM Iron Mountain Incorporated $117.16 -3.89% $34.86B 62
VICI VICI Properties $27.18 +3.48% 30B 97
EXR Extra Space Storage Inc. $149.29 +1.36% $31.54B 62
AVB AvalonBay Communities, Inc. $193.96 +1.85% $27.52B 76
LTC LTC Properties, Inc. $45.52 +1.56% 66
STRW Strawberry Fields REIT LLC $13.77 -0.07% $184.88M 60
WELL Welltower Inc. $235.84 +2.45% $166.48B 58

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are VTR's Key Strengths?

  • Diversified portfolio of healthcare properties
  • Strategic partnerships with leading care providers and research institutions
  • Experienced management team
  • Strong balance sheet

What Are VTR's Weaknesses?

  • Exposure to interest rate fluctuations
  • Dependence on the healthcare industry
  • High P/E ratio
  • Gross Margin is negative

What Could Drive VTR Stock Higher?

  • Strategic acquisitions of healthcare properties to expand the portfolio.
  • Development projects to create new senior housing communities and medical office buildings.
  • Integration of technology solutions to enhance the tenant experience and improve operational efficiency.
  • Demographic trends driving increased demand for healthcare services.

What Are the Key Risks for VTR?

  • Financial-distress signal — its Altman Z-Score of 1.76 sits in the distress zone (elevated bankruptcy risk).
  • Rich valuation — a P/E of 153.0 runs well above the Real Estate sector’s ~20x, leaving little room for a miss.
  • Regulatory changes in the healthcare industry could impact revenue and profitability.
  • Rising interest rates could increase borrowing costs and reduce investment returns.
  • Economic downturn could reduce demand for healthcare services and impact occupancy rates.
  • Competition from other REITs and healthcare providers could put pressure on rental rates and occupancy rates.
  • Fluctuations in property values could impact the company's net asset value.

What Are the Growth Opportunities for VTR?

  • Growth opportunity 1: Expansion of Life Science Portfolio: Ventas has the opportunity to expand its life science real estate portfolio, capitalizing on the growing demand for research and development facilities. The global life science tools market is projected to reach $170 billion by 2028, presenting a significant growth opportunity for Ventas. By investing in state-of-the-art facilities and partnering with leading research institutions, Ventas can attract high-quality tenants and generate long-term revenue growth. This strategy aligns with the increasing focus on innovation and drug development in the healthcare industry.
  • Growth opportunity 2: Strategic Acquisitions: Ventas can pursue strategic acquisitions of healthcare properties to expand its portfolio and diversify its revenue streams. The REIT market is fragmented, offering opportunities to acquire undervalued assets with growth potential. By carefully selecting acquisitions that align with its investment criteria, Ventas can enhance its market position and improve its financial performance. This strategy requires thorough due diligence and effective integration to ensure successful outcomes. Ventas can target specific geographic markets or property types to optimize its portfolio mix.
  • Growth opportunity 3: Development Projects: Ventas can undertake development projects to create new healthcare facilities that meet the evolving needs of its tenants and customers. This includes building new senior housing communities, medical office buildings, and life science facilities. By developing properties from the ground up, Ventas can customize the design and features to attract high-quality tenants and generate higher returns. This strategy requires careful planning, execution, and risk management to ensure successful project completion. Ventas can leverage its expertise in real estate development to create value for its shareholders.
  • Growth opportunity 4: International Expansion: Ventas can explore opportunities to expand its operations internationally, capitalizing on the growing demand for healthcare services in other countries. This includes investing in healthcare properties in developed and emerging markets. By diversifying its geographic footprint, Ventas can reduce its exposure to regional economic and regulatory risks. This strategy requires careful consideration of local market conditions, cultural differences, and regulatory requirements. Ventas can partner with local experts to navigate the complexities of international expansion.
  • Growth opportunity 5: Technology Integration: Ventas can integrate technology solutions into its properties to enhance the tenant experience and improve operational efficiency. This includes implementing smart building technologies, telehealth platforms, and data analytics tools. By leveraging technology, Ventas can attract tech-savvy tenants and optimize its property management processes. This strategy requires investment in technology infrastructure and training for employees. Ventas can partner with technology providers to develop innovative solutions that meet the specific needs of its tenants and customers.

What Opportunities Does VTR Have?

  • Expansion of life science portfolio
  • Strategic acquisitions
  • Development projects
  • International expansion

What Threats Does VTR Face?

  • Regulatory changes in the healthcare industry
  • Economic downturn
  • Increased competition
  • Rising interest rates

What Are VTR's Competitive Advantages?

  • Diversified portfolio of healthcare properties
  • Strategic partnerships with leading care providers and research institutions
  • Experienced management team with a proven track record
  • Strong balance sheet and access to capital

What Does VTR Do?

Ventas, Inc. operates at the intersection of the healthcare and real estate industries. Founded over twenty years ago, the company has grown into one of the world's foremost Real Estate Investment Trusts (REITs). Ventas strategically employs capital to unlock the value of real estate, forging partnerships with leading care providers, developers, research and medical institutions, innovators, and healthcare organizations. Ventas' success is driven by the demographic tailwind of an aging population, which increases the demand for healthcare and senior living facilities. Ventas owns or manages approximately 1,200 properties through unconsolidated joint ventures. The company's portfolio includes senior housing communities, medical office buildings, and life science facilities. Ventas focuses on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. Ventas' strategy combines a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team.

What Products and Services Does VTR Offer?

  • Owns and manages a diversified portfolio of healthcare properties.
  • Invests in senior housing communities, medical office buildings, and life science facilities.
  • Partners with leading care providers, developers, and research institutions.
  • Provides capital to unlock the value of real estate in the healthcare sector.
  • Manages approximately 1,200 properties through unconsolidated joint ventures.
  • Focuses on producing consistent growing cash flows and superior returns.

How Does VTR Make Money?

  • Generates revenue through rental income from its healthcare properties.
  • Acquires and develops healthcare properties to expand its portfolio.
  • Manages its properties to optimize occupancy rates and rental rates.
  • Finances its operations through a combination of debt and equity.

What Industry Does VTR Operate In?

Ventas, Inc. operates within the REIT - Healthcare Facilities industry, which is driven by the increasing demand for healthcare services due to the aging population. The industry is characterized by long-term leases and stable cash flows. Ventas competes with other REITs, healthcare providers, and real estate developers. The market is influenced by factors such as interest rates, regulatory changes, and demographic trends. Ventas' diversified portfolio and strategic partnerships position it as a key player in this competitive landscape. The healthcare REIT sector is expected to continue growing, driven by the increasing demand for senior housing, medical office buildings, and life science facilities.

Who Are VTR's Key Customers?

  • Senior housing operators
  • Medical office tenants
  • Life science companies
  • Healthcare providers
AI Confidence: 83% Updated: May 5, 2026

Company Profile

Ventas, Inc. operates in the REIT - Healthcare Facilities industry within the Real Estate sector. It is headquartered in Chicago, US. The company is led by CEO Debra A. Cafaro. VTR has traded publicly since 1997.

How Ventas, Inc. Is Valued

Ventas, Inc. carries a market capitalization of $45.00B, placing it in the large-cap category. Relative to its peer group, VTR's quantitative score of 52/100 is below the peer average of 70/100.

ROE 2%Key Financial Metrics

Return on equity for Ventas, Inc. stands at 2.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.9%, showing how much profit it generates from its asset base. VTR trades at a trailing price-to-earnings ratio of 152.95, above the Real Estate sector average of ~20x. Its free cash flow yield is 1.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.15 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.6%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 5/9Financial Health

Ventas, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.76 places it in the distress zone, a signal of elevated financial risk.

FY2026 estForward Outlook

Wall Street analysts project Ventas, Inc. revenue of about $6.81B for fiscal 2026, with EPS near $0.62. The estimate reflects 4 contributing analysts.

Net buyingInsider Activity

Over the past six months, Ventas, Inc. insiders filed 30 SEC Form 4 transactions — 4 sales and 26 purchases. On net that is roughly 20K shares acquired (about $1.8M) — insiders putting money in tends to read as conviction.

VTR Financials

Fundamental Snapshot

Revenue Growth (FY)
+18.5%
Net Income Growth (FY)
+209.8%
EPS Growth (FY)
+175.0%
Free Cash Flow Growth (FY)
+24.6%
P/E (TTM)
169
Return on Equity (TTM)
+2.1%
Current Ratio
0.1
EV/EBITDA (TTM)
23.5

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Ventas has seen increased insider buying, indicating confidence from leadership in the company's future.
  • Recent community sentiment has turned positive, with discussions highlighting the stability of the healthcare real estate sector.
  • Investors are optimistic about the potential for growth in senior living facilities as demand rises due to an aging population.
  • Market perception is shifting favorably as Ventas is positioned to benefit from long-term demographic trends.

Bear Case

  • Concerns remain about the impact of rising interest rates on real estate investments, particularly in the healthcare sector.
  • Some community members express skepticism regarding Ventas's ability to maintain occupancy rates in its properties post-pandemic.
  • Recent earnings reports have raised questions about revenue growth, leading to bearish sentiment among analysts.
  • The competitive landscape in healthcare real estate is intensifying, leading to fears of margin compression.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

From the Earnings Call

“Based on our first quarter results and our confidence, we have improved our outlook for the full year, increasing our mid guidance for FFO per share by $0.03 to $3.86 per share, led by SHOP same-store growth of 16%.”

— Debra A. Cafaro, Chairman and CEO

“Ventas, Inc. continues to drive growth and outperformance as a leading participant in the longevity economy. We are already into our fifth consecutive year of double-digit annual growth in our senior housing operating portfolio, or SHOP.”

— Debra A. Cafaro, Chairman and CEO

VTR Q1 FY2026 earnings call transcript · 2026-04-28

VTR Latest News

VTR Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for VTR.

Price Targets

Consensus target: $98.22

VTR MoonshotScore

52/100

What does this score mean?

The MoonshotScore rates VTR's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Debra A. Cafaro

Chairman and Chief Executive Officer

Debra A. Cafaro has served as Chairman and CEO of Ventas, Inc. since 1999. She has extensive experience in the real estate and healthcare industries. Before joining Ventas, she was the President of Ambassador Apartments, Inc. Ms. Cafaro holds a J.D. from the University of Chicago Law School and a B.A. from the University of Notre Dame. She is a member of the National Association of Real Estate Investment Trusts (NAREIT) and serves on the board of directors of several organizations.

Track Record: Under Debra Cafaro's leadership, Ventas has grown from a small company to a leading S&P 500 REIT. She has overseen the acquisition and development of numerous healthcare properties, expanding the company's portfolio and revenue streams. Cafaro has also implemented strategic initiatives to improve operational efficiency and enhance shareholder value. She is recognized as one of the most influential leaders in the real estate industry.

Common Questions About VTR (Real Estate)

What does Ventas, Inc. do?

Ventas, Inc. is a leading Real Estate Investment Trust (REIT) that owns, manages, and develops healthcare properties. The company's portfolio includes senior housing communities, medical office buildings, and life science facilities. Ventas partners with leading care providers, developers, and research institutions to provide capital and unlock the value of real estate in the healthcare sector. The company generates revenue through rental income from its properties and aims to provide consistent growing cash flows and superior returns to its shareholders.

What do analysts say about VTR stock?

Analyst consensus on VTR stock is mixed, with some analysts rating it as a buy and others as a hold. Key valuation metrics include the company's P/E ratio of 153.0 and dividend yield of 2.26%. Analysts are focused on Ventas' ability to grow its revenue and earnings, as well as its exposure to interest rate fluctuations and regulatory changes in the healthcare industry. The company's diversified portfolio and strategic partnerships are seen as positive factors, while its high P/E ratio is a potential concern.

What are the main risks for VTR?

The main risks for Ventas, Inc. include regulatory changes in the healthcare industry, rising interest rates, and an economic downturn. Regulatory changes could impact the company's revenue and profitability, while rising interest rates could increase borrowing costs and reduce investment returns. An economic downturn could reduce demand for healthcare services and impact occupancy rates. Additionally, competition from other REITs and healthcare providers could put pressure on rental rates and occupancy rates. Fluctuations in property values could also impact the company's net asset value.

How does Ventas, Inc. compare to competitors in its industry?

Ventas, Inc. competes with other REITs that specialize in healthcare properties, such as Welltower (WELL) and Healthpeak Properties (PEAK). Ventas differentiates itself through its diversified portfolio, strategic partnerships, and experienced management team. The company's focus on senior housing, medical office buildings, and life science facilities provides a balanced approach to the healthcare real estate market. Ventas' strong balance sheet and access to capital also give it a competitive advantage in acquiring and developing new properties.

What are the key financial metrics investors watch for VTR?

Key financial metrics that investors watch for Ventas, Inc. include its funds from operations (FFO), net operating income (NOI), occupancy rates, and dividend yield. FFO is a measure of a REIT's cash flow from operations and is used to evaluate its profitability. NOI is a measure of the income generated from a property after deducting operating expenses. Occupancy rates indicate the percentage of occupied space in a property. The dividend yield is the annual dividend payment divided by the stock price and is a measure of the return on investment.

What are the key factors to evaluate for VTR?

Ventas, Inc. (VTR) holds an AI score of 52/100 (moderate). P/E: 153.0x vs the S&P 500's ~20-25x. Analysts target $98.22 (+6%). Not financial advice.

How frequently does VTR data refresh on this page?

VTR prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven VTR's recent stock price performance?

Ventas, Inc. (VTR) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified portfolio of healthcare properties. See the News tab for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The information provided is based on available data and is subject to change.
  • This is not investment advice. Please consult with a financial professional before making any investment decisions.
Data Sources

Popular Stocks